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During thoracic operations, it is sometimes difficult todetermine the route of collateral circulation of the tho-racic duct, the site of chyle leakage, or both. In addi-tion, the dynamics of lymph flow in the thoracic duct in
diseased patients are impossible to understand with routine radio-
logic examinations, such as plain film, magnetic resonance imag-
ing, and chest computed tomography (CT). Several diseases
involve the thoracic duct, such as chylothorax,1,2 lymphangiomy-
omatosis, and lymphangiectasia.3 We herein report the case of a
patient with a disorder of the thoracic duct in whom we success-
fully detected multiple flow routes of chyle, its abnormal accumu-
lation in the mediastinum, and its influx into the blood circulation
after the oral administration of iodine 123–labeled (123I) 15-(p-
iodophenyl)-3-R, S-methyl pentadecanoic acid (BMIPP).4
The patient was a 50-year-old woman who had an abnormal
shadow in the medial side of the right lower lung field. Chest CT
revealed a tumor-like soft tissue mass 3 × 3 cm in size with fat
density in the right lower anterior mediastinum and right thoracic
effusion, suggesting diaphragmatic hernia (Figure 1, A). She was
transferred to our hospital because of a slight increase of tumor
size and dyspnea, and thoracotomy was carried out in June 1999.
Operative findings showed a yellow, solid mass with pleural effu-
sion identified as chyle. Macroscopically, we diagnosed her con-
dition as liposarcoma with invasion to the thoracic duct. We
removed the tumor and ligated the thoracic duct just above the
diaphragm. Her condition was excellent after the operation.
However, on postoperative day 13, a chest radiograph and a CT
scan (Figure 1, B) showed dilatation of the mediastinum and right
pleural effusion, and thus tube drainage was undertaken.
Histologic examination revealed a granulomatous lesion with
marked dilatation of the lymphatic vessels, suggesting occlusion
or marked stenosis of the thoracic duct.
We performed contrast lymphangiography after cannulation of
an afferent lymph vessel on the dorsum of the left foot but failed to
detect the lymphatic flow in the mediastinum. Then 123I-BMIPP, a
radiolabeled long-chain fatty acid that is usually used for car-
diomyoscintigraphy, was administered orally and was subsequent-
ly imaged by means of radioisotope scintigraphy. Plasma activities
of 123I-BMIPP were also monitored. Figure 1, D, shows a scinti-
scan of this patient 300 minutes after administration of 123I-BMIPP.
There were 3 routes of upward flow from the diaphragm and 3
transverse communications between them. At the left side of the
aortic arch, marked accumulation of the isotope was also present.
These scintiscans in the upper mediastinum of the patient were
visualized 200 minutes after oral administration, whereas those of
normal volunteers were visualized about 100 minutes after admin-
istration (Figure 1, C). Abnormal accumulation of the isotope was
also observed the day after the examination. On the basis of these
findings, we speculate that the influx of chyle into the blood circu-
lation from the thoracic duct was severely impaired. However, the
plasma activities of 123I-BMIPP after its oral administration grad-
ually increased (Figure 2). This means that the thoracic duct was
not obstructed completely. Low-fat diet therapy was carried out for
about a month, and the drainage tube was then removed. The
patient was discharged from our hospital and had not had enlarge-
ment of the mediastinum or pleural effusion as of November 2000.
In this case we initially failed to demonstrate the thoracic duct
with lymphangiography, which is generally performed to visualize
lymphatic ducts. One of the possible reasons for this was that the
lymph flow from the left foot was diluted by the lymph flow from the
small intestine. We subsequently attempted to visualize the thoracic
duct with scintigraphy using 123I-BMIPP. 123I-BMIPP, which is usu-
ally used for cardiomyoscintigraphy, is a long-chain fatty acid. When
orally administered, it is absorbed by the intestinal lymphatics and
then flows and passes through the thoracic duct. Kettner and col-
leagues5 have also reported lymphoscintigraphy with 123I-iodophenyl
pentadecanoic acid (123I-IPPA), another type of long-chain fatty acid,
to visualize the thoracic duct and to detect sites of lymphatic leakage.
In our hospital 123I-IPPA is not used for scintigraphy, whereas
132I-BMIPP is commonly used for cardiomyoscintigraphy. We
applied 123I-BMIPP to visualize the thoracic duct because both
materials are similar in structure.
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On the basis of our experience, it was easy to visualize the tho-
racic duct, as well as the collateral circulation, transverse commu-
nications, and abnormal accumulation of chyle. In addition,
sequential monitoring of plasma 123I-BMIPP activities helped us to
understand the dynamics of the chyle flow in this patient. We were
afraid of complete loss of lymphatic influx into the venous circu-
lation in the present case, but fortunately, this was denied by the
results of the examination with 123I-BMIPP. Although the patho-
genesis of the disease is hardly understood, our experience showed
the possibility of understanding of the dynamics of lymph flow in
the thoracic duct in diseased individuals. On the basis of the results
of scintigraphy, we chose conservative management, resulting in
successful control of fluid accumulation in the thorax and medi-
astinum and eventual discharge of the patient from our hospital.
Our experience showed that lymphoscintigraphy with orally
administrated 123I-BMIPP and subsequent monitoring of plasma
123I-BMIPP activities is useful for understanding diseases of the
thoracic duct without any complications or invasiveness. The tho-
racic duct, collateral flows, leakage site, and abnormal pooling in
the mediastinum can be visualized with this method. Combined
Figure 1. Chest CT and scintiscans after oral administration of 123I-BMIPP. A, Chest CT at admission. Arrows indi-
cate a tumor-like mass with fat density. B, Chest CT 13 days after operation. At the left side of the aortic arch,
marked accumulation was present. C, Scintiscan of a representative normal volunteer at 100 minutes after oral
administration. The small arrow indicates the normal thoracic duct. D, Scintiscan of the patient at 300 minutes
after oral administration. There were 3 routes of upward flow (small arrows). In the upper mediastinum 3 trans-
verse communications were also detected. At the left side of the aortic arch, marked pooling of the isotope
(large arrow) was also present.
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with subsequent monitoring of plasma 123I-BMIPP activities, the
dynamics of thoracic lymph flow can also be elucidated. Thus,
these methods may be recommended as safe for patients with dis-
eases of the thoracic duct.
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Figure 2. Plasma 123I-BMIPP activities after oral administration.
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